Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7849853
Reference Type
Journal Article
Title
Characterization of the binding affinity between some anti-Parkinson agents and Mn2+, Fe3+& nbsp; and Zn2+& nbsp; metal ions: A DFT insight
Author(s)
Kaviani, S; Shahab, S; Sheikhi, M; Khaleghian, M; Al Saud, S
Year
2021
Is Peer Reviewed?
Yes
Journal
Inorganic Chemistry Communications
ISSN:
1387-7003
Volume
128
DOI
10.1016/j.inoche.2021.108582
Web of Science Id
WOS:000649670400006
Abstract
In the current work, density functional theory calculations were carried out to evaluate the potential ability of apomorphine, dopamine, hinokitiol and deferiprone chelating agents to coordinate Mn2+, Fe3+ and Zn2+ metal ions with a 1:1 ratio in water solution. The binding energy values reveal that Zn2+/chelating agent complexes are more stable compared to Mn2+/chelating agent and Fe3+/chelating agent complexes. In order to evaluate the parameters that describe the affinity between the metal ions and chelating agents, the metal ion/chelating agent interactions were analyzed by CDA, NBO, QTAIM, FMO analyses. Interestingly, it was found that the Fe-O interactions in all complexes and Mn-O interactions in [Mn-DFP]+ complex are mainly electrostatic, whereas other interactions have a covalent character. Moreover, TD-DFT studies showed n -> pi* and pi -> pi* transitions in the absorption spectra of the complexes.
Keywords
Chelating agent; DFT; Metal ion; Parkinson’ s disease; Binding affinity
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity